Form 4: Medpace Holdings Director Dani S. Zander Acquires Stock Options
SEC Form 4 Filing
Director Dani S. Zander acquired stock options in Medpace Holdings, Inc. on July 1, 2024.
Summary
- On July 1, 2024, Dani S. Zander, a director of Medpace Holdings, Inc., acquired 824 stock options at a price of $407.24.
- These options vest on the earlier of the day before the first annual meeting following the grant date or the first anniversary of the grant date, contingent upon continued service on the board.
- Following the transaction, Zander directly owns 824 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The acquisition of options by a director is generally viewed as a positive signal, but it's not a major event.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of the stock option transaction. |
| 07/01/2024 | Date the option was granted. |
| 07/01/2031 | Expiration date of the stock options. |
| 07/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.